Multimedia

Psoriasis Therapy During the COVID-19 Pandemic: Should Patients Continue Biologics?

Author and Disclosure Information

Psoriasis patients are reaching out to their dermatologists with concerns about taking biologics and the risk for coronavirus disease 2019 (COVID-19). Dr. Lawrence Green provides his recommendation, which is for patients to continue their biologics. "If you stop your biologic, and it will take a few months for your psoriasis to come back, but when that happens, if you go back to where you were you're at much more risk for COVID-19 infection than you are right now taking your biologic and controlling your disease," he reports. If patients have had exposure to COVID-19 or develop symptoms, they should stop biologics immediately. Patients taking biologics should exercise extra precautions, as recommended by the Centers for Disease Control and Prevention, to prevent infection.


 

Vidyard Video

Recommended Reading

DIY masks: Worth the risk? Researchers are conflicted
Covid ICYMI
New ASAM guideline released amid COVID-19 concerns
Covid ICYMI
Emergency Rule: Docs can bill for telehealth and COVID-19 tests. Here’s how
Covid ICYMI
Preventable diseases could gain a foothold because of COVID-19
Covid ICYMI
Flu now riding on COVID-19’s coattails
Covid ICYMI
Managing the COVID-19 isolation floor at UCSF Medical Center
Covid ICYMI
Should patients with COVID-19 avoid ibuprofen or RAAS antagonists?
Covid ICYMI
SECURE-IBD registry traces COVID-19 in patients with Crohn’s, colitis
Covid ICYMI
Webinar confronts unique issues for the bleeding disorders community facing COVID-19
Covid ICYMI
Amid hydroxychloroquine hopes, lupus patients face shortages
Covid ICYMI